How should we dose antibiotics for pneumonia in the ICU?
- 1 April 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 26 (2) , 189-195
Abstract
Pneumonia continues to be a common reason for, or complication of, ICU admission. Associated morbidity and mortality remain high, with an increasing incidence of multidrug-resistant organisms. Appropriate antibiotic therapy, both in terms of spectrum of cover and dose, remains the cornerstone of effective management. Critically ill patients will frequently manifest significantly altered end-organ function, as compared with an ambulatory or ward-based setting. Such changes can have profound effects on antibiotic drug handling, promoting subtherapeutic concentrations, treatment failure or the selection of resistant organisms. Standard antibiotic regimens typically fail to consider such issues, with recent literature highlighting the need for improved dosing to achieve sufficient intrapulmonary concentrations, particularly in the setting of augmented elimination. Although recent clinical trials utilizing strategies that optimize drug exposure (either through the use of agents with improved penetration, or continuous infusions) demonstrate superior surrogate outcomes, a mortality benefit is still uncertain. Antibiotic dosing strategies that are adapted to a critical care environment are urgently needed, both to improve clinical outcomes and ensure therapeutic longevity. Similarly, study protocols investigating emerging antibiotics must also be designed accordingly, to prevent potential setbacks in drug availability.Keywords
This publication has 36 references indexed in Scilit:
- Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomesBMC Infectious Diseases, 2012
- Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjectsJournal of Antimicrobial Chemotherapy, 2012
- Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumoniaJournal of Antimicrobial Chemotherapy, 2012
- Penetration of Vancomycin into Epithelial Lining Fluid in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2011
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining FluidClinical Pharmacokinetics, 2011
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- The Pharmacokinetic and Pharmacodynamic Properties of VancomycinClinical Infectious Diseases, 2006
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory ConcentrationThe Journal of Infectious Diseases, 1987